Fundz

Cellphire Therapeutics, Inc. Closes $15 Million Series A Funding Round Led By Simcah Management

PRIVATEApr 02, 2021

Amount Raised

$15 Million

Round Type

Series A

RockvilleBiotechnology

Description

Cellphire Therapeutics, Inc., the global leader in long-term stabilization and storage of platelets, announced today the close of a $15 million Series A financing round led by Simcah Management.

Quick answer

Cellphire Therapeutics raised $15 Million in a Series A round, dated April 2, 2021. Cellphire Therapeutics is based in Rockville, Maryland, United States.

How much did Cellphire Therapeutics raise?
Cellphire Therapeutics raised $15 Million in a Series A round on April 2, 2021.
What does Cellphire Therapeutics do?
Cellphire Therapeutics, Inc. is a Rockville, Maryland-based biotechnology company developing next-generation therapeutics.
Where is Cellphire Therapeutics based and how big is it?
Cellphire Therapeutics is based in Rockville, Maryland, United States. Fundz records about 48 employees.
Who are the decision-makers at Cellphire Therapeutics?
Fundz holds 1 contact at Cellphire Therapeutics, including the Chief Medical Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Cellphire Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Axtria raised $100M on May 17, 2021.
  • AssayQuant Technologies, Inc. raised $5.1M (Seed) on May 14, 2021.
  • GIOCOV Ltd raised an undisclosed amount on May 14, 2021.
  • Shifa Biomedical Corp raised $1.8M (Seed) on May 14, 2021.
  • Harrow raised $11M on May 14, 2021.
  • Vaxess Technologies raised $25M on May 14, 2021.

Who to call at Cellphire Therapeutics, and when

A new round usually means Cellphire Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cellphire Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cellphire Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cellphire Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cellphire Therapeutics

Location

9430 KEY WEST AVENUE, SUITE 250

Rockville, Maryland, United States

About

Cellphire Therapeutics, Inc. is a Rockville, Maryland-based biotechnology company developing next-generation therapeutics. The company is applying its proprietary cell stabilization technology to all cell types, including platelets, to develop lifesaving products. Its lead product, Thrombosomes®, a freeze-dried hemostatic agent derived from human platelets, is currently in a Phase I clinical trial. Cellphire’s technology has potential applications across a wide range of medical applications from trauma to wound care, imaging, targeted drug delivery, and regenerative medicine.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cellphire Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsDamien B., Chief Medical OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Cellphire Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Cellphire Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.